ARCHIVES

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

EMEND Improved Emesis In Men And Women, Trials Find

December 26, 2003

In Brief: OMB Still Dragging Its Feet On New Construction Money Schmidt Pressure Gets 70 Slots For NCI

May 23, 1975

Nobelist Offer “Electronic” Theory Of Cancer

June 27, 1975

Funding Opportunity: NYC-based Research Alliance Offering $200,000 Per Year for Young Investigators

October 3, 2014

CMS Abandons Proposal To Require Further Certification Of Clinical Trials For Coverage.

October 19, 2007